Aurobindo Integrates Apotex And Prepares For Sandoz
Firm Says Nothing ‘Extraneous’ Holding Up FTC Nod For Sandoz Deal
Aurobindo believes it has “substantially addressed” all requirements for an FTC go-ahead for its acquisition of Sandoz’s US dermatology and generic oral solids businesses. The integration of the acquired Apotex business in Europe is also shaping up.
